Ascendis Pharma
ASND
ASND
58 hedge funds and large institutions have $1.04B invested in Ascendis Pharma in 2017 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
16.71% more ownership
Funds ownership: 71.6% → 88.3% (+17%)
Holders
58
Holding in Top 10
8
Calls
–
Puts
–
Top Buyers
| 1 | +$23.4M | |
| 2 | +$22.7M | |
| 3 | +$21.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$20.5M |
| 5 |
DM
Deerfield Management
New York
|
+$15.6M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$15.4M | |
| 3 | -$1.63M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.17M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$15.9K |